Highlights from the latest articles in diabetes pharmacogenomics.
Laboratory of Pharmacology & Clinical Pharmacology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece. emanolop@med.duth.gr
Georgia
G
Ragia
Vangelis G
VG
Manolopoulos
D002318:Cardiovascular Diseases / Q000235:genetics*; D003324:Coronary Artery Disease / Q000201:enzymology*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000201:enzymology* / Q000235:genetics*; D003925:Diabetic Angiopathies / Q000201:enzymology*; D004487:Edema / Q000139:chemically induced*; D005260:Female; D056726:Genetic Association Studies; D014644:Genetic Variation / Q000235:genetics*; D018149:Glucose Intolerance / Q000235:genetics*; D005979:Glutathione Peroxidase / Q000235:genetics*; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000097:blood*; D008297:Male; D008687:Metformin / Q000097:blood*; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000235:genetics*; D054419:Receptors, Adiponectin / Q000235:genetics*; D045162:Thiazolidinediones / Q000009:adverse effects*
D005979:Glutathione Peroxidase; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D008687:Metformin; D016660:NAD(P)H Dehydrogenase (Quinone); D054419:Receptors, Adiponectin; D045162:Thiazolidinediones